Skip to main content

Table 2 Intraoperative fluid management as well as perioperative blood consumption intraoperatively, postoperatively and overall

From: Goal-directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia

Fluid management and blood transfusion CTRL group GDT group P value
Intraoperative period    
   Dobutamine, n (%) 0 (0%) 11 (55%) 0.0003
   Dobutamine dose, μg/kg/minute n/a 4 ± 1 n.a.
   Mean Crystalloids (± SD), mL 2,100 ± 361 3,358 ± 825 < 0.0001
   Mean Colloids (± SD), mL 535 ± 86 2,079 ± 858 < 0.0001
   Mean Blood (± SD), mL 0 595 ± 316 0.0003
   Mean Total input (± SD), mL 2,635 ± 346 6,032 ± 1,388 < 0.0001
   Median Urine output (IQR), mL 300 (100 to 475) 1225 (650 to 1375) < 0.0001
   Median Blood loss (IQR), mL 900 (800 to 975) 900 (750 to 1200) n.s.
   Mean Fluid balance (± SD), mL 1,403 ± 401 3565 ± 879 < 0.0001
Perioperative blood transfusion requirements, mL    
   Mean Intraoperative blood transfusion (± SD) 0 565 ± 332 0.0003
   Mean Postoperative blood transfusion (± SD) 658 ± 302 198 ± 292 0.0004
   Mean Total blood transfusion (± SD) 658 ± 302 792 ± 480 n/s
  1. CTRL: control; GDT: goal-directed therapy; n/a: not applicable; n/s: not significant.
  2. P values are reported if statistically significant.